“…Compared to EGFR TKIs for direct oncoprotein binding, targeting DNA G-quadruplex (G4) structures at oncogene proximal promoters for transcription inhibition represents an alternative approach for selective EGFR downregulation. − G4s are four-stranded nucleic acid secondary structures formed by the stacking of two or more G-tetrads with Hoogsteen hydrogen bonds and stabilized by K + or Na + that centrally coordinated with O6 of the tetrad guanines. − DNA G4 structures have been visualized in human cells, and endogenous G4s are enriched in the proximal promoters of highly expressed cancer genes. − The genome functions of G4s are implicated in gene transcription, replication, translation, genome instability, and epigenetic regulation. ,− Stabilizing DNA G4 structures at MYC , , KRAS , , c- KIT , , VEGF, , PDGFR- β, − and many other oncogene promoters ,− with G4-specific small molecules leads to oncogene transcription repression and, subsequently, cancer cell death, suggesting that proximal promoter G4s are a promising biomolecular target for cancer therapy. ,, …”